Cite

HARVARD Citation

    Liu, D. et al. (2022). GSTT1, an increased risk factor for prostate cancer in patients with metabolic syndrome. Journal of clinical laboratory analysis. 36 (4), p. n/a. [Online]. 
  
Back to record